The Italian lender announced the approval on 8 September. It will apply the treatment, known as the Danish Compromise, from its third-quarter reporting.
The change allows insurance investments to be risk-weighted rather than deducted from regulatory capital. UniCredit calculated the expected benefit using its position at the end of the second quarter. A 52-basis-point improvement is equivalent to 0.52 percentage points.
The decision fulfils the bank’s stated intention to obtain approval by the end of September. It removes a supervisory condition from a benefit already included in its financial planning; it does not represent an injection of new cash into the group.
How the capital treatment changes
Banks’ common equity tier one, or CET1, ratios compare their highest-quality regulatory capital with risk-weighted assets. The treatment of a large insurance investment can affect that calculation even when the underlying business has not changed.
The ECB’s explanation of the Danish Compromise places it within the rules for financial conglomerates. Ordinarily, a deduction addresses the risk that capital is counted more than once across banking and insurance businesses. EU rules permit supervisors to allow qualifying insurance holdings to be risk-weighted instead.
The exemption does not remove insurance risk from the group. In its June discussion of conglomerate supervision, the ECB noted that changes in the value of insurers’ investments can feed into a banking group’s capital position, depending on its structure and regulatory treatment.
For UniCredit, the numerical effect had already been illustrated in its second-quarter results. The bank reported a CET1 ratio of 14.3 per cent, or 14.5 per cent excluding a temporary effect associated with its increased Commerzbank position.
It then presented a 15 per cent pro-forma ratio incorporating both the reversal of that temporary effect and the anticipated Danish Compromise approval. That figure should not be confused with the reported second-quarter ratio, or with an actual third-quarter result that has yet to be released.
The approval comes while UniCredit’s position in Commerzbank remains a separate corporate and political issue. EU Today has reported on Berlin’s direct talks with UniCredit over the German lender. The insurance-capital decision concerns the group’s prudential calculations, not approval of a Commerzbank transaction.
UniCredit’s July results also envisaged approximately €2.8bn in interim cash dividends for 2026, subject to the required decisions and procedures. The bank said the amount would be determined by the board meeting approving its third-quarter results.
The new capital treatment forms part of that next reporting period, alongside changes in profits, lending, risk-weighted assets and the bank’s investment holdings. Those movements will determine the reported ratio, rather than the 52-basis-point estimate alone.
UniCredit has scheduled its third-quarter results board meeting for 21 October. Its published timetable envisages payment of the interim dividend on 25 November, following the necessary approvals.
Post Views: 1,068